Oral fluconazole treatment for extensive cutaneous leishmaniasis in an 11-year-old child

Pediatric Infectious Disease Journal

Volumn 25, Issue 11, 2006, Pages 1083-1084

  Toubiana, Julie ^a,b   Armengaud, Jean Baptiste ^a   Camet, Jean Dupouy ^a   Gendrel, Dominique ^a,b  

^a Institut Cochin   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Cutaneous leishmaniasis; Fluconazole; Leishmania major

Indexed keywords

AMOXICILLIN; FLUCONAZOLE; MEGLUMINE ANTIMONATE;

ABSENCE OF SIDE EFFECTS; ANEMIA; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; LABORATORY TEST; LEISHMANIA MAJOR; LIVER DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; SKIN INFECTION; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTIFUNGAL AGENTS; CHILD; FEMALE; FLUCONAZOLE; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; TREATMENT OUTCOME;

EID: 33750435586     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000242968.36675.64     Document Type: Article

References (12)

1. Urbanization an increasing risk factor for leismaniasis: WHO Wkly Epidemiol Rec. 2002;44:1.
2. Al-Tawfiq JA, AbuKhamsin A. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956-2002). Int J Infect Dis. 2004;8:244-250.
3. Uzun S, Durdu M, Culha G, et al. Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey. J Parasitol. 2004;90:853-859.
4. Kharfi M, Benmously R, El Fekih N, et al. Childhood leishmaniasis: report of 106 cases. Dermatol Online J. 2004;10:6.
5. Alrajhi AA, Ibrahim EA, De Vol EB, et al. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med. 2002;346:891-895.
6. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2006;366:1561-1577.
7. Baron S, Laube S, Moss C, et al. Cutaneous leishmaniasis in a Kosovan child treated with oral fluconazole. Clin Exp Dermatol. 2004;29:546-547.
8. Jones J, Bowling J, Watson J, et al. Old world cutaneous leishmaniasis infection in children: a case series. Arch Dis Child. 2005;90:530-531.
9. Dedet JP, Marchand JP, Strobel M, et al. Ecology of a focus of cutaneous leishmaniasis in the Thies region (Senegal, West Africa): Epidemiologic and clinical characteristics of the human disease. Bull Soc Pathol Exot Filiales. 1982;75(5, pt 2):568-76.
10. Gangneux JP, Menotti J, Lorenzo F, et al. Prospective value of PCR amplification and sequencing for diagnosis and typing of old world Leishmania infections in an area of non-endemicity. J Clin Microbiol. 2003;41:1419-1422.
11. Belazzoug S, Ammar-Khodja A, Pratlong F, et al. Leishmania major MON-117, an agent of cutaneous leishmaniasis in Mauritania. Ann Parasitol Hum Comp. 1992;67:62.
12. Moosavi Z, Nakhli A, Rassaii S. Comparing the efficiency of topical paromomycine with intralesional meglumine antimoniate for cutaneous leishmaniasis. Int J Dermatol. 2005;44:1064-1065.